𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erratum: Comparing exercie in Parkinson's disease—The Berlin LSVT®BIG study

✍ Scribed by G. Ebersbach; A Ebersbach; D Edler; O Kaufhold; M Kusch; A Kupsch; J Wissel

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
27 KB
Volume
25
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparing exercise in Parkinson's diseas
Comparing exercise in Parkinson's disease—the Berlin BIG Study
✍ Georg Ebersbach; Almut Ebersbach; Daniela Edler; Olaf Kaufhold; Matthias Kusch; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

## Abstract Physiotherapy is widely used in Parkinson's disease (PD), but there are few controlled studies comparing active interventions. Recently, a technique named “LSVT®BIG” has been introduced. LSVT®BIG is derived from the Lee Silverman Voice Treatment and focuses on intensive exercising of hi

Comparative study of selegiline plus L-d
Comparative study of selegiline plus L-dopa–carbidopa versus L-dopa–carbidopa alone in the treatment of parkinson's disease
✍ Timothy Brannan; Dr. Melvin D. Yahr 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 1 views

The long-term effect of selegiline (L-deprenyl) in the treatment of Parkinson's disease has not been clearly delineated. We report on a group of patients whose treatment was initiated with selegiline (n = 43) and then subsequently included L-dopa-carbidopa (Sinemet) and in whom an extended period o

The Parkinson–Control study: A 1-year ra
The Parkinson–Control study: A 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease
✍ Alexandre Castro-Caldas; Paul Delwaide; Wolfgang Jost; Marcelo Merello; Adrian W 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

## Abstract Dopamine agonists have been recommended as early treatment for Parkinson's disease (PD), alone or combined with levodopa. Piribedil is a non‐ergot selective D~2~/D~3~ agonist with α~2~ antagonist properties shown to be effective in the treatment of PD. This 12‐month international, rando

Long-term mortality results of the rando
Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease
✍ Jean-Louis Montastruc; Karine Desboeuf; Maryse Lapeyre-Mestre; Jean-Michel Senar 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB

## Abstract The present paper compares, in terms of mortality, two treatment regimens for Parkinson's disease (PD), i.e., bromocriptine later combined with levodopa versus levodopa only. Between 1982 and 1989, 60 PD patients (29 treated with levodopa alone [group D] and 31 receiving first bromocrip